Online citations, reference lists, and bibliographies.

Cortical Superficial Siderosis Progression In Cerebral Amyloid Angiopathy

Thanakit Pongpitakmetha, Panagiotis Fotiadis, Marco Pasi, G. Boulouis, Li Xiong, A. Warren, K. Schwab, J. Rosand, M. E. Gurol, S. Greenberg, A. Viswanathan, A. Charidimou
Published 2020 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Objective To investigate the prevalence, predictors, and clinical relevance of cortical superficial siderosis (cSS) progression in cerebral amyloid angiopathy (CAA). Methods Consecutive patients with symptomatic CAA meeting Boston criteria in a prospective cohort underwent baseline and follow-up MRI within 1 year. cSS progression was evaluated on an ordinal scale and categorized into mild (score 1–2 = cSS extension within an already present cSS focus or appearance of 1 new cSS focus) and severe progression (score 3–4 = appearance of ≥2 new cSS foci). Binominal and ordinal multivariable logistic regression were used to determine cSS progression predictors. We investigated future lobar intracerebral hemorrhage (ICH) risk in survival analysis models. Results We included 79 patients with CAA (mean age, 69.2 years), 56 (71%) with lobar ICH at baseline. cSS progression was detected in 23 (29%) patients: 15 (19%) patients had mild and 8 (10%) severe progression. In binominal multivariable logistic regression, ICH presence (odds ratio [OR], 7.54; 95% confidence interval [CI], 1.75–53.52; p = 0.016) and baseline cSS (OR, 10.41; 95% CI, 2.84–52.83; p = 0.001) were independent predictors of cSS progression. In similar models, presence of disseminated (but not focal) cSS at baseline (OR, 5.58; 95% CI, 1.81–19.41; p = 0.004) was an independent predictor of cSS progression. Results were similar in ordinal multivariable logistic regression models. In multivariable Cox regression analysis, severe cSS progression was independently associated with increased future ICH risk (HR, 5.90; 95% CI, 1.30–26.68; p = 0.021). Conclusions cSS evolution on MRI is common in patients with symptomatic CAA and might be a potential biomarker for assessing disease severity and future ICH risk. External validation of these findings is warranted.
This paper references
10.1161/STROKEAHA.117.016833
Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease
Frank Wollenweber (2017)
10.1212/WNL.0000000000003281
Cortical superficial siderosis predicts early recurrent lobar hemorrhage
D. Roongpiboonsopit (2016)
10.1161/STROKEAHA.115.008778
Contribution of Convexal Subarachnoid Hemorrhage to Disease Progression in Cerebral Amyloid Angiopathy
Markus Beitzke (2015)
10.1212/WNL.0b013e3181eee40f
Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy
A. Biffi (2010)
10.1212/WNL.0000000000001288
Cortical superficial siderosis
Han Kyu Na (2015)
10.1212/WNL.56.4.537
Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
Katherine A Knudsen (2001)
10.1148/radiol.2481071158
Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection.
Meike W. Vernooij (2008)
10.1016/J.NEURAD.2011.11.006
Séquences IRM « SWAN, SWI et VenoBOLD » exploitant le phénomène de susceptibilité magnétique : principes techniques et applications cliniques
J. Hodel (2012)
10.1212/WNL.50.4.961
Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
S. Greenberg (1998)
10.1007/978-1-4757-3294-8
Modeling Survival Data: Extending the Cox Model
Terry M. Therneau (2001)
10.1007/978-0-387-21706-2
Modern Applied Statistics with S
William N. Venables (2010)
10.1212/WNL.0000000000001398
Cerebral amyloid angiopathy with and without hemorrhage
A. Charidimou (2015)
10.1016/S0140-6736(07)61602-X
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik Von Elm (2007)
10.1212/01.wnl.0000191403.95453.6a
Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy
M. E. Gurol (2006)
10.1093/brain/awv162
Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions.
A. Charidimou (2015)
10.1002/ana.22516
Cerebral amyloid angiopathy in the elderly.
A. Viswanathan (2011)
10.1016/j.mri.2012.05.001
3D Slicer as an image computing platform for the Quantitative Imaging Network.
Andriy Fedorov (2012)
10.1161/01.STR.0000126807.69758.0e
Hemorrhage Burden Predicts Recurrent Intracerebral Hemorrhage After Lobar Hemorrhage
S. Greenberg (2004)
10.1212/WNL.0000000000004665
Cortical superficial siderosis multifocality in cerebral amyloid angiopathy
A. Charidimou (2017)
10.1212/WNL.0000000000004235
Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation
Eleni Korompoki (2017)
10.1007/s00234-013-1175-4
Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings
Andreas Charidimou (2013)
10.1212/01.wnl.0000435298.80023.7a
Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy
Andreas Charidimou (2013)
10.1212/WNL.0000000000000732
Posterior white matter disease distribution as a predictor of amyloid angiopathy
Sekh Thanprasertsuk (2014)
10.3233/JAD-150890
Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit.
L. Xiong (2016)
10.1016/j.neurobiolaging.2010.01.019
ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy
S. Domingues-Montanari (2011)
10.3174/ajnr.A1355
MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength
R. Nandigam (2009)
10.1212/WNL.0000000000004259
Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds
A. Charidimou (2017)
10.1177/0271678X16647396
Reproducibility and variability of quantitative magnetic resonance imaging markers in cerebral small vessel disease
Francois De Guio (2016)
10.1212/WNL.0b013e3181dad605
Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy
Jennifer Linn (2010)
10.1161/STROKEAHA.114.005787
Aspirin should be discontinued after lobar intracerebral hemorrhage.
Guido J. Falcone (2014)
10.1001/jama.2015.10082
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
A. Biffi (2015)
10.1016/j.neurad.2011.11.006
[Susceptibility weighted magnetic resonance sequences "SWAN, SWI and VenoBOLD": technical aspects and clinical applications].
J. Hodel (2012)
10.1016/S1474-4422(09)70013-4
Cerebral microbleeds: a guide to detection and interpretation
Steven M. Greenberg (2009)
10.1007/978-0-387-98141-3
ggplot2 - Elegant Graphics for Data Analysis
Hadley Wickham (2009)
10.1212/WNL.0b013e3182a08f2c
Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy
Andreas Charidimou (2013)
10.1016/j.jns.2016.11.021
The Cerebral Haemorrhage Anatomical RaTing inStrument (CHARTS): Development and assessment of reliability
Andreas Charidimou (2017)
10.1016/S1474-4422(13)70124-8
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
J. Wardlaw (2013)
10.1161/STROKEAHA.114.005786
Antiplatelet therapy may be continued after intracerebral hemorrhage.
Rustam Al-Shahi Salman (2014)
10.1001/jamaneurol.2015.4078
Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation.
E. Auriel (2016)
10.1093/brain/awx047
Emerging concepts in sporadic cerebral amyloid angiopathy.
A. Charidimou (2017)
10.1212/WNL.0000000000003866
Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy
A. Charidimou (2017)
10.1212/WNL.0b013e3181c34a7d
The Microbleed Anatomical Rating Scale (MARS)
Simone M. Gregoire (2009)
10.1212/WNL.0000000000005778
Cortical superficial siderosis
Solène Moulin (2018)
10.1212/WNL.0000000000000984
Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy
A. Shoamanesh (2014)
10.1001/jamaneurol.2016.2619
Association of Key Magnetic Resonance Imaging Markers of Cerebral Small Vessel Disease With Hematoma Volume and Expansion in Patients With Lobar and Deep Intracerebral Hemorrhage.
G. Boulouis (2016)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar